For MASLD this has mainly focused on liver-related outcomes, although the potential impact on other related diseases ( e.g., cardiovascular disease, extrahepatic malignancy) and quality of life are increasingly being explored (including in interventional trials) as part of a more holistic approach
In this study, we did not restrict either the GLP-1 treatment cohort or the control cohort to any specific medication regimen, dosage trajectory or adjunctive interventions, as the intent was to capture the full range of possible real-world medication usage that is occurring
Replace cup of flour with bran for added fibre
The main concern is that reduced appetite could lead to inadequate calorie intake, which might affect milk supply
Glucagon increases energy expenditure independently of brown adipose tissue activation in humans
Ask a clinical question and tap into Healio AI's knowledge base